Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)
Old Forum Content for RCKT
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- joelsg1: @woodman $TSLA $EOSE As our Biotech maven, what do you think of $RCKT?
- woodman: @joelsg1 $TSLA $EOSE $RCKT - Sorry, I don't know anything about it. I'll have to take a look. Biotech has been so lousy for quite some time. And then there's the head-scratcher of immensely unqualified RFK, Jr. to lead healthcare in the U.S., if confirmed. I don't think the pharma/biotech industry has much of a grasp of what that will mean. My biotech positions are $ARDX (bought back mostly between around $4.70 to to $4.90 and a little more at $5.20 - of note, insider (Director) David Mott recently bought $1 million worth of stock at $4.67) and $HUMA (bought back between ~$4.90 and ~$5.05). My ARDX (small-medium position) is larger than my HUMA (small). I also have a little (even smaller position in) $TGTX and $AUPH, and a mere placeholder in a few others just so I don't forget about them. All in all, a relatvely low concentration in biotech.
- joelsg1: @woodman $TSLA $EOSE $RCKT $ARDX $HUMA $TGTX $AUPH Appreciate that, thanks. $RCKT is Rev Shark's stock of the year with many shots on goal so value your thoughts.
-
champ: @woodman $TSLA $EOSE $RCKT $ARDX $HUMA $TGTX $AUPH ....RFK, Jr is a Environmental Lawyer,...I was just thinking, who's to say that he is Not qualified to hirer all the right type of people, to do all the work that is now needed......
....he is a perf ... - Bs7518: @woodman $TSLA $EOSE $RCKT $ARDX $HUMA $TGTX $AUPH What are your thoughts on $VKTX? I've held a small position in it (cardinal Sin) but still believe in the science?
- greenpatrol: $RCKT just triggered an inside month and up at 62.98
- romanalexk: $RCKT. Just watching. Power play.
- Herb: $RCKT a rocket!
- scottrades: My notes for today: $SPY Nice bounce, weak into the close. $QQQ Ditto $GDX Holding above 29 $NUGT Holding at the Middle Bband $FNV Possible pullback entry today. $KL Still in Jail. Support at the 200 Day $NEM Strong Weekly uptrend $AUY Weekly Squeeze, still have it $GOLD Weekly Squeeze, higher low today. $AEM Nice move at the open and then a fade, but still a higher low. $KGC Nice volume into the close. $SSRM Looks like the rest, higher low. $SVM Weekly higher lows. Good Squeezes are hard to come by in this mess. But consider looking at: $DGX Earnings Thursday. $CMTL Trades thin. $RCKT Biotech (Risky). Sitting on the 50 Day. 16 Days of Short Interest. $UFI Trying to move out of a Squeeze. Watch above 27.
- traderbren: $RCKT - nice push off the 20d. Looks to be gaining traction here. NP.
- bRobert: $RCKT Spec biotech from the Renaissance 13F . 22% short 30d to cover. Long sideways consolidation. Breakout. Retest. Bounce. Watching for a sustained move higher. Much higher. Again, this is a spec. Small position is better. Add on strength with a proven thesis
- spmeyers: $RCKT came out of a very nice volatility squeeze a couple weeks ago, and now seems to be lifting off again
- success: #morningtrade . . $RCKT
- success: #morningtrades follow-up . . ended up with $VIPS +1% and now out . . missed my price for entry and got in late and $RCKT . . up 4.5% now with a tight trailing stop . . the other two items were not bought
- PJMR11: @success $VIPS $RCKT #morningtrades Still holding VIPS but not sure there is another move up. Watching closely.
- success: $RCKT - closed out of VIPS
- success: @success $RCKT . . now out of RCKT for a 4.5% return . .
| Stock Price | $3.39 |
| Change | -1.74% |
| Volume | 1,618,420 |
Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of therapies for diseases of the eye, primarily Glaucoma. Its main product candidate is Trabodenoson monotherapy. The company's product pipeline includes Trabodenoson monotherapy in an eye drop formulation and also trabodenoson plus latanoprost in an eye drop formulation.
Request Video of RCKTAlready a member? Sign in here.
Past Month
Leading Peers
-
$26.02 153.79%
-
$33.05 142.61%
-
$16.56 89.15%
Past Month
Lagging Peers
-
$15.30 -58.16%
-
$27.27 -44.32%
-
$19.51 -43.69%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!